Azeliragon ameliorates Alzheimer’s disease via the Janus tyrosine kinase and signal transducer and activator of transcription signaling pathway. Clinics, [S. l.], v. 76, p. e2348, 2021. DOI: 10.6061/clinics/2021/e2348. Disponível em: https://www.revistas.usp.br/clinics/article/view/192073.. Acesso em: 3 may. 2024.